KSC 2020 | 64th Annual Scientific Meeting of The Korean Society of Cardiology

10:20 - 10:30
No : 254
[640305]

Antiplatelet Therapy in Patients with Acute Myocardial Infarction Who had a History of Prior Percutaneous Coronary Intervention.

[Speaker] Woohyeun Kim,Korea
Woohyeun Kim¹, Seung-Woon Rha¹, Byoung Geol Choi¹, Se Yeon Choi¹, Jae Kyeong Byun¹, Jinah Cha¹, Dong Oh Kang, MD¹, Cheol Ung Choi¹, Myung Ho Jeong² and Other Korea Acute Myocardial Infarction Registry (KAMIR)-National Institutes of Health (NIH) investigators
¹Cardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea. ²Heart Center of Chonnam National University Hospital, Gwangju, Republic of Korea

10:30 - 10:40
No : 255
[640144]

Comparison of adverse effects Clopidogrel versus Ticagrelor in Korean patients with ACS intended for invasive management

[Speaker] Ae Ran Jeoung,Korea
Ae Ran JEOUNG
Chonnam National University Hospital

10:40 - 10:50
No : 256
[640180]

Prasugrel versus Ticagrelor in Late Comer ST Elevation Myocardial Infarction Patients; from Korea Acute Myocardial Infarction Registry-National Institute of Health

[Speaker] Joon Ho Ahn,Korea
Joon Ho Ahn¹, Myung Ho Jeong^1*, Min Chul Kim¹, Doo Sun Sim¹, Young Joon Hong¹, Ju Han Kim¹, Youngkeun Ahn¹, Shung-Chull Chae², In Whan Seong³, Jong Sun Park⁴, Jei Keon Chae⁵, Seung Ho Hur⁶, Kwang-Soo Cha⁷, Hyo-Soo Kim⁸, Hyeon Cheol Gwon⁹, Ki Bae Seung¹⁰, Seung Woon Rha¹¹ and other Korea Acute Myocardial Infarction Registry Investigators.
¹Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ²Department of Cardiology, Kyungpook National University Hospital, Daegu, Korea. ³Deparment of Cardiology, Chungnam National University Hospital, Daejeon, Korea. ⁴Department of Cardiology, Yeungnam University Hospital, Daegu, Korea. ⁵Department of Cardiology, Chonbuk National University Hospital, Jeonju, Korea^{. 6}Department of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea. ⁷Department of Cardiology, Pusan National University Hospital, Busan, Korea. ⁸Department of Cardiology, Seoul National University Hospital, Seoul, Korea. ⁹Department of Cardiology, Samsung Medical Center, Seoul, Korea. ¹⁰Department of Cardiology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea. ¹¹Department of Cardiology, Korean University Guro Hospital, Seoul, Korea.

10:50 - 11:00
No : 257
[640386]

CYP2C19 Genotype and Clinical Outcomes in Korean Patients with Coronary Artery Disease: Single Center Result from PCI-Platelet Function Registry

[Speaker] Moo Hyun Kim,Korea
Cai De Jin¹^,2, Moo Hyun Kim¹*, Kwang Min Lee¹, Hye Yeon Moon¹, Yoon Sung Jo¹, Chan Ho Yoon¹, Young-Rak Cho¹, Jong Sung Park¹, Khyung Hee Lim¹
1 Department of Cardiology, Dong-A University Hospital, Busan, Republic of Korea 2 Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

11:00 - 11:10
No : 258
[640229]

Efficacy, Optimal Duration and Safety of Adjunctive Cilostazol in Acute ST-elevation Myocardial Infarction Patients undergoing Primary Percutaneous Coronary Intervention with Drug-eluting Stents

[Speaker] Soohyung Park,Korea
Soohyung Park¹, Byoung Geol Choi¹, Se Yeon Choi¹, Jae Kyeong Byun¹, Jin Ah Cha¹, Kyuho Lee¹, Seungmin Back¹, Jieun Lee¹, Dong Oh Kang¹, Woohyeun Kim¹, Jah Yeon Choi¹, Seung-Young Roh¹, Jin Oh Na¹, Cheol Ung Choi¹, Jin Won Kim¹, Eung Ju Kim¹, Chang Gyu Park¹, Hong Seog Seo¹and Seung -Woon Rha¹
¹Cardiovascular Center Korea University Guro Hospital

11:10 - 11:20
No : 259
[640325]

Which antiplatelet combination is the optimal therapy for the clinical outcome in AMI?- Triple with cilostazol Versus Dual with potent P2Y12 inhibitor Versus standard Dual antiplatelet therapy in patients with acute myocardial infarction

[Speaker] Su Nam Lee,Korea
Su Nam Lee¹, Ik Jun Choi², Sungmin Lim³, Eun Ho Choo⁴and Kiyuk Chang⁴
¹Division of Cardiology, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea ²Division of Cardiology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea ³Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea ⁴Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

11:20 - 11:30
No : 260
[640517]

Efficacy of high-intensity statin on long-term cardiovascular outcomes in stable 1 year survivors with well-controlled LDL-cholesterol levels after acute myocardial infarction

[Speaker] Jae Ho Byeon,Korea
Jaeho BYEON¹, Youngkeun Ahn², Myung Ho Jeong² and Kiyuk Chang¹
¹Cardiovascular Center and Cardiology Division, Seoul St. Mary’s Hospital, Seoul, Korea ²Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea

11:30 - 11:40
No : 261
[640296]

Different Clinical Impact of Statin-intensity according to age in Patients with Acute Myocardial Infarction

[Speaker] Kyusup Lee,Korea
Kyusup Lee, Dae-Won Kim, Mahn-Won Park
Daejeon St. Mary's Hospital

Program at a Glance